Letrozole Bluefish

Letrozole, the active ingredient in Letrozole Bluefish, is a aromatase inhibitor presented as an oral tablet for oral use. It is employed to treat hormone receptor‑positive breast cancer in postmenopausal women by lowering estrogen levels.

GNH USA supplies Letrozole Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Letrozole is an aromatase inhibitor used in the management of estrogen‑dependent breast cancer. It works by suppressing estrogen production, which is essential for tumor growth.

- Hormone receptor‑positive breast cancer (postmenopausal): Reduces estrogen to inhibit tumor progression. - Adjuvant therapy for early‑stage disease: Decreases risk of recurrence after surgery. - Metastatic breast cancer (postmenopausal): Controls disease spread by maintaining low estrogen levels.

Letrozole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Hot flashes: Sudden feeling of warmth and sweating. - Joint and muscle pain: Arthralgia or myalgia. - Fatigue: Persistent tiredness. - Nausea: Mild to moderate upset stomach. - Headache: Tension‑type or migraine‑like. - Dizziness: Light‑headed sensations.

Serious or Rare Side Effects: - Severe liver injury: Jaundice or elevated liver enzymes. - Bone fractures: Increased risk of osteoporosis‑related breaks. - Pulmonary embolism: Sudden shortness of breath or chest pain. - Allergic reactions: Rash, swelling, or anaphylaxis. - QT interval prolongation: Potential cardiac arrhythmias. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating letrozole therapy, several safety considerations should be reviewed.

- Pregnancy: Contraindicated (Category X); teratogenic risk. - Breastfeeding: Not recommended; drug may pass into milk. - Bone health: Monitor bone mineral density; consider calcium/vitamin D supplementation. - Liver function: Assess hepatic status; adjust if significant impairment. - Drug interactions: Review concomitant medications for potential interactions. - Store at ambient temperature: Keep below 25°C in original packaging, protect from moisture and light.

Letrozole can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Tamoxifen: Antagonistic effect reduces therapeutic benefit. - Estrogen replacement therapy: Counteracts letrozole’s action. - Strong CYP2A6 inhibitors (e.g., ketoconazole): May increase letrozole plasma levels.

Moderate Interactions (Monitor Closely): - Warfarin: Potential increase in INR; monitor coagulation. - CYP2C19 substrates (e.g., omeprazole): May alter metabolism; observe clinical response. - Diuretics: May affect electrolyte balance; watch for dehydration. - Selective serotonin reuptake inhibitors: Possible additive fatigue. - Anticonvulsants (e.g., carbamazepine): May reduce letrozole exposure; consider dose adjustment.